Description
| Specialty | COARAVEN |
|---|---|
| Dosage | 300 mg , 25 mg |
| Form | Film-coated tablet |
| Presentation | Box of 90 |
| Primary Packaging | Blister |
| Specification | Opaque white PVC/PVDC/Alu |
| INN | HYDROCHLOROTHIAZIDE, IRBESARTAN |
| VEIC Classification | Essential |
| Therapeutic Class | CARDIOVASCULAR SYSTEM |
| Sub-Class | Agents Acting on the Renin-Angiotensin System |
| Laboratory | PHILADELPHIA PHARMA |
| Schedule | A |
| Shelf Life | 24 months |
| Generic/Reference | Generic |
| Marketing Authorization (MA) | 93530410 |
| MA Date | 2014-08-12 |
| Range | Cardio-Metabolic |
Reviews
There are no reviews yet.